BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692726)

  • 1. Hepatitis C antibody after kidney transplantation: clinical significance.
    Marcen R; Gamez C; Mateos ML; Orofino L; Teruel JL; Serrano P; Pascual J; Quereda C; Nash R; Ortuño J
    Am J Nephrol; 1993; 13(3):184-9. PubMed ID: 7692726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in kidney transplant recipients.
    Lau JY; Davis GL; Brunson ME; Qian KP; Lin HJ; Quan S; DiNello R; Polito AJ; Scornik JC
    Hepatology; 1993 Nov; 18(5):1027-31. PubMed ID: 7693567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication.
    Genescà J; Vila J; Córdoba J; Sauleda S; Quer J; Esteban JI; Esteban R; Piera L; Guardia J
    J Hepatol; 1995 Mar; 22(3):272-7. PubMed ID: 7608477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
    Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
    Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion".
    Ragni MV; Ndimbie OK; Rice EO; Bontempo FA; Nedjar S
    Blood; 1993 Aug; 82(3):1010-5. PubMed ID: 7687887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.
    Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ
    Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
    Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
    Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
    Monteleone PM; Andrzejewski C; Kelleher JF
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
    Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
    J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
    Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
    Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation anti-HCV tests predict infectivity.
    Larsen J; Skaug K; Maeland A
    Vox Sang; 1992; 63(1):39-42. PubMed ID: 1384236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
    Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
    Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation.
    Teo CG; Gabriel FG; Mortimer PP
    J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.